Exploring the role of a combined anti-MicroRNA-21 and TIMP3 mRNA nanotherapy interplay in modulating TIMP-3 expression: Implications for aortic aneurysm and cancer progression

C. Bofill-Bonet; C. Fornaguera; S. Borros

Exploring the role of a combined anti-MicroRNA-21 and TIMP3 mRNA nanotherapy interplay in modulating TIMP-3 expression: Implications for aortic aneurysm and cancer progression

Research output: Indexed journal article › Meeting Abstract › peer-review

Original language	English
Pages (from-to)	A234-A234
Number of pages	1
Journal	Human Gene Therapy
Volume	35
Issue number	3-4
Publication status	Published - Feb 2024
Event	30th Annual Congress of the European Society of Gene and Cell Therapy (ESGCT) - Brussels, Belgium Duration: 24 Oct 2023 → 27 Oct 2023

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

SDG 3 Good Health and Well-being

Cite this

@article{f3251ed7b3504d9590a640bc37998ead,

title = "Exploring the role of a combined anti-MicroRNA-21 and TIMP3 mRNA nanotherapy interplay in modulating TIMP-3 expression: Implications for aortic aneurysm and cancer progression",

author = "C. Bofill-Bonet and C. Fornaguera and S. Borros",

year = "2024",

month = feb,

language = "English",

volume = "35",

pages = "A234--A234",

journal = "Human Gene Therapy",

issn = "1043-0342",

publisher = "Raz{\'o}n y Fe",

number = "3-4",

note = "30th Annual Congress of the European Society of Gene and Cell Therapy (ESGCT) ; Conference date: 24-10-2023 Through 27-10-2023",

}

TY - JOUR

T1 - Exploring the role of a combined anti-MicroRNA-21 and TIMP3 mRNA nanotherapy interplay in modulating TIMP-3 expression

T2 - 30th Annual Congress of the European Society of Gene and Cell Therapy (ESGCT)

AU - Bofill-Bonet, C.

AU - Fornaguera, C.

AU - Borros, S.

PY - 2024/2

Y1 - 2024/2

UR - https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=pure_univeritat_ramon_llull&SrcAuth=WosAPI&KeyUT=WOS:001422165502078&DestLinkType=FullRecord&DestApp=WOS_CPL

M3 - Meeting Abstract

SN - 1043-0342

VL - 35

SP - A234-A234

JO - Human Gene Therapy

JF - Human Gene Therapy

IS - 3-4

Y2 - 24 October 2023 through 27 October 2023

ER -

Exploring the role of a combined anti-MicroRNA-21 and TIMP3 mRNA nanotherapy interplay in modulating TIMP-3 expression: Implications for aortic aneurysm and cancer progression

UN SDGs

Other files and links

Cite this